Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-001774

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Matthew D Perry
Director · Other
Period of report
May 17, 2018
Accepted (ET)
May 21, 2018 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———43,139D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (Right to Buy)F1,F2$4.61May 17, 2018A60,000A—May 17, 2028Common Stock60,00060,000D
Stock Option (Right to Buy)F1,F3$4.25holding————Feb 22, 2027Common Stock50,00050,000D

Explanation of responses